Qingsong Health (02661) has announced that Ms. Wang Jing has retired from her roles as executive director and chief financial officer, effective April 17, 2026. Her decision was based on a desire to dedicate more time to other personal commitments. Following her resignation as an executive director, Ms. Wang will also step down from her position as the company's authorized representative under Rule 3.05 of the Listing Rules. After her retirement, Ms. Wang will be appointed as a senior advisor to the company starting April 18, 2026, where she will continue to provide advisory support for the group's strategic development and capital operations.
Also effective April 17, 2026, Mr. Bai Kun has resigned from his positions as an independent non-executive director, chairman of the board's audit committee, and member of the remuneration committee due to other personal business interests.
Effective from the same date, Ms. Yang Yin, an executive director, has been appointed as the authorized representative. Ms. Ji Wenting has been appointed as an independent non-executive director of the company, and will also assume the roles of chairman of the board's audit committee and member of the remuneration committee.
Comments